Aaron E. Lottes

1.2k total citations
21 papers, 796 citations indexed

About

Aaron E. Lottes is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Aaron E. Lottes has authored 21 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Aaron E. Lottes's work include Peripheral Artery Disease Management (13 papers), Vascular Procedures and Complications (8 papers) and Coronary Interventions and Diagnostics (7 papers). Aaron E. Lottes is often cited by papers focused on Peripheral Artery Disease Management (13 papers), Vascular Procedures and Complications (8 papers) and Coronary Interventions and Diagnostics (7 papers). Aaron E. Lottes collaborates with scholars based in United States, Japan and Germany. Aaron E. Lottes's co-authors include Michael D. Dake, Thomas Zeller, Marc Bosiers, Dierk Scheinert, A Wagner, M Reiser, D. Seidel, Dorothea Nagel, Konstantin Nikolaou and Christoph R. Becker and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Gut.

In The Last Decade

Aaron E. Lottes

19 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron E. Lottes United States 12 514 511 259 84 57 21 796
Megan Fiasconaro United States 13 112 0.2× 278 0.5× 163 0.6× 61 0.7× 18 0.3× 38 509
Sevdenur Çizginer United States 13 237 0.5× 524 1.0× 441 1.7× 22 0.3× 27 0.5× 29 767
Hirotada Tajiri Japan 11 317 0.6× 362 0.7× 98 0.4× 15 0.2× 21 0.4× 31 526
Caroline Van De Wauwer Netherlands 15 189 0.4× 417 0.8× 42 0.2× 16 0.2× 107 1.9× 36 582
Jacques P. Fontaine United States 15 449 0.9× 271 0.5× 130 0.5× 18 0.2× 14 0.2× 69 600
Petra Neuhaus Germany 11 170 0.3× 303 0.6× 40 0.2× 35 0.4× 26 0.5× 31 711
Elizabeth David Canada 12 105 0.2× 215 0.4× 73 0.3× 62 0.7× 54 0.9× 31 328
Ravi Moonka United States 15 400 0.8× 537 1.1× 265 1.0× 80 1.0× 14 0.2× 36 779
Paul Audu United States 9 179 0.3× 141 0.3× 75 0.3× 23 0.3× 8 0.1× 14 361
Sebastian Fähndrich Germany 13 236 0.5× 65 0.1× 54 0.2× 23 0.3× 95 1.7× 40 435

Countries citing papers authored by Aaron E. Lottes

Since Specialization
Citations

This map shows the geographic impact of Aaron E. Lottes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron E. Lottes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron E. Lottes more than expected).

Fields of papers citing papers by Aaron E. Lottes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron E. Lottes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron E. Lottes. The network helps show where Aaron E. Lottes may publish in the future.

Co-authorship network of co-authors of Aaron E. Lottes

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron E. Lottes. A scholar is included among the top collaborators of Aaron E. Lottes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron E. Lottes. Aaron E. Lottes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Iwamoto, Shin, Kenneth J. Cavanaugh, Misti Malone, et al.. (2023). Global Medical Device Clinical Trials Involving Both the United States and Japan: Key Considerations for Development, Regulatory Approval, and Conduct. Cardiovascular revascularization medicine. 52. 67–74. 2 indexed citations
3.
Ye, Wei, Weiguo Fu, Changwei Liu, et al.. (2022). First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study. Frontiers in Cardiovascular Medicine. 9. 877578–877578.
4.
Lottes, Aaron E., Kenneth J. Cavanaugh, Vincent J. Devlin, et al.. (2022). Navigating the Regulatory Pathway for Medical Devices—a Conversation with the FDA, Clinicians, Researchers, and Industry Experts. Journal of Cardiovascular Translational Research. 15(5). 927–943. 32 indexed citations
5.
Bertges, Daniel J., Jens Eldrup‐Jorgensen, Misti Malone, et al.. (2021). Vascular Quality Initiative Surveillance of Femoropopliteal Artery Paclitaxel Devices. JACC: Cardiovascular Interventions. 14(23). 2598–2609. 8 indexed citations
6.
7.
Dake, Michael D., Fabrizio Fanelli, Aaron E. Lottes, et al.. (2020). Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent. CardioVascular and Interventional Radiology. 44(2). 196–206. 8 indexed citations
8.
Sugimoto, Masayuki, Kimihiro Komori, Hiroyoshi Yokoi, et al.. (2020). Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance Study. Journal of Endovascular Therapy. 28(2). 229–235. 9 indexed citations
9.
Bausback, Yvonne, Andrej Schmidt, Thomas Zeller, et al.. (2019). Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease. Journal of the American College of Cardiology. 73(6). 667–679. 109 indexed citations
10.
Dake, Michael D., Gary M. Ansel, Marc Bosiers, et al.. (2019). Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices. CardioVascular and Interventional Radiology. 43(1). 8–19. 40 indexed citations
11.
Kichikawa, Kimihiko, Shigeo Ichihashi, Hiroyoshi Yokoi, et al.. (2018). Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results. CardioVascular and Interventional Radiology. 42(3). 358–364. 20 indexed citations
12.
Ogawa, Yukihisa, Hiroyoshi Yokoi, Takao Ohki, et al.. (2017). Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan. CardioVascular and Interventional Radiology. 40(11). 1669–1677. 12 indexed citations
13.
Cipollari, Stefano, Hiroyoshi Yokoi, Takao Ohki, et al.. (2017). Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels—Results from the Zilver PTX Japan Post-Market Surveillance Study. Journal of Vascular and Interventional Radiology. 29(1). 9–17.e1. 12 indexed citations
14.
Ansel, Gary M., Michael R. Jaff, Jeffrey J. Popma, et al.. (2017). A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal Stents in Symptomatic Patients With Femoropopliteal Disease. Journal of Endovascular Therapy. 24(4). 499–503. 5 indexed citations
15.
Yokoi, Hiroyoshi, Takao Ohki, Kimihiko Kichikawa, et al.. (2016). Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan. JACC: Cardiovascular Interventions. 9(3). 271–277. 64 indexed citations
16.
17.
Graser, Anno, P Stieber, Dorothea Nagel, et al.. (2008). Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut. 58(2). 241–248. 291 indexed citations
18.
Lottes, Aaron E., et al.. (2007). Sustained abdominal compression during CPR raises coronary perfusion pressures as much as vasopressor drugs. Resuscitation. 75(3). 515–524. 18 indexed citations
19.
Geddes, L. A., et al.. (2007). A new cardiopulmonary resuscitation method using only rhythmic abdominal compression. The American Journal of Emergency Medicine. 25(7). 786–790. 21 indexed citations
20.
Geddes, L. A., et al.. (2006). The natural biochemical changes during ventricular fibrillation with cardiopulmonary resuscitation and the onset of postdefibrillation pulseless electrical activity. The American Journal of Emergency Medicine. 24(5). 577–581. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan Fiasconaro Breakdown of academic impact, for papers by Sevdenur Çizginer Breakdown of academic impact, for papers by Hirotada Tajiri Breakdown of academic impact, for papers by Caroline Van De Wauwer Breakdown of academic impact, for papers by Jacques P. Fontaine Breakdown of academic impact, for papers by Petra Neuhaus Breakdown of academic impact, for papers by Elizabeth David Breakdown of academic impact, for papers by Ravi Moonka Breakdown of academic impact, for papers by Paul Audu Breakdown of academic impact, for papers by Sebastian Fähndrich
Rankless by CCL
2026